AGIO — Agios Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Agios Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	565	573	1,020	783	777
Net Total Accounts Receivable
Net Total Receivables	15.3	25.4	4.38	2.21	2.81
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	612	637	1,064	833	834
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	126	118	104	88.1	69.8
Long Term Investments
Other Long Term Assets
Total Assets	891	853	1,438	1,239	937
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	92.9	94.4	59.8	62.6	68
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	250	453	146	138	126
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	641	400	1,292	1,101	811
Total Liabilities & Shareholders' Equity	891	853	1,438	1,239	937
Total Common Shares Outstanding
Total Preferred Shares Outstanding